false 0001873875 0001873875 2024-12-11 2024-12-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

  

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 11, 2024

 

Incannex Healthcare Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41106   93-2403210
(State or other Jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

Suite 105, 8 Century Circuit Norwest,
NSW 2153 Australia		   Not applicable
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, including Area Code: +61 409 840 786

 

(Former Name or Former Address, if Changed Since Last Report): Not Applicable

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of exchange on which registered
Common Stock, $0.0001 par value per share   IXHL   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

  

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On December 11, 2024 at 10:00 a.m. Eastern Time, Incannex Healthcare Inc. (the “Company”), held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”), at the offices of the Company’s outside legal counsel, Mintz, located at 919 Third Avenue, New York, NY 10022. Of the Company’s 17,642,832 shares of common stock issued and outstanding and eligible to vote as of the record date of October 24, 2024, a quorum of 7,661,666 shares, or approximately 43.42% of the eligible shares, was present in person or represented by proxy. Each of the matters set forth below is described in detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on November 12, 2024. The following actions were taken at the Annual Meeting:

 

Proposal 1

 

Election of the following nominee as a director of the Company, to serve until the 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.

 

   Votes For   Votes Withheld   Broker Non-Vote 
Peter Widdows   5,540,460    283,676    1,837,530 

 

Proposal 2

 

Ratification of the appointment of Grant Thornton Audit Pty Ltd as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2025.

 

Votes For   Votes Against   Votes Abstained   Broker Non-Vote
7,519,726   134,469   7,471   —

 

Proposal 3

 

Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of the Company’s issued and outstanding common stock pursuant to an equity line of credit agreement with Arena Business Solutions Global SPC II, Ltd (“Arena Global”), dated September 6, 2024, including commitment fee shares and a warrant issued to Arena Global.

 

Votes For   Votes Against   Votes Abstained   Broker Non-Vote
5,694,614   122,754   6,768   1,837,530

 

Proposal 4

 

Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of the Company’s issued and outstanding common stock pursuant to a securities purchase agreement with the purchasers set forth on the signature pages therein (the “Purchasers”), dated September 6, 2024, including upon the conversion of debentures issued or issuable to Purchasers and upon the exercise of debenture warrants issued or issuable to Purchasers.

 

Votes For   Votes Against   Votes Abstained   Broker Non-Vote
5,689,790   127,578   6,768   1,837,530

 

Proposal 5

 

Approval of a postponement or adjournment of the Annual Meeting, from time to time, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to adopt the proposals set forth above or to establish a quorum.

 

Votes For   Votes Against   Votes Abstained   Broker Non-Vote
7,280,429   379,829   1,408   —

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Incannex Healthcare Inc.
     
Date: December 11, 2024   /s/ Joel Latham
  Name:  Joel Latham
  Title: Chief Executive Officer and President

 

2

 

v3.24.3
Cover
Dec. 11, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 11, 2024
Entity File Number 001-41106
Entity Registrant Name Incannex Healthcare Inc.
Entity Central Index Key 0001873875
Entity Tax Identification Number 93-2403210
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One Suite 105
Entity Address, Address Line Two 8 Century Circuit Norwest
Entity Address, City or Town NSW
Entity Address, Country AU
Entity Address, Postal Zip Code 2153
City Area Code +61
Local Phone Number 409 840 786
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol IXHL
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Incannex Healthcare (NASDAQ:IXHL)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Incannex Healthcare Charts.
Incannex Healthcare (NASDAQ:IXHL)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Incannex Healthcare Charts.